EUVIMEDEUVIMED entdecken
Open Access

A preliminary characterization of cannabis oil use and vaporization among individuals who use for medical purposes: A pilot study.

Jacqueline E Smith iD, Elizabeth R Aston, Samantha G Farris

Experimental and Clinical Psychopharmacology · 2024

DOI: 10.1037/pha0000672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Psychopharmacology, 2024. Verfasst von Jacqueline E Smith und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Rutgers. Hauptthemen laut MEDLINE: Cannabis, Marijuana Smoking, Hallucinogens, Substance-Related Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Brown University, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Little is known about the naturalistic use of cannabis oil vaporization, a high-potency product with the ability to be administered discreetly. This pilot study evaluated the feasibility of utilizing a "smart" vaporizer and application to assess the timing, frequency, socioenvironmental factors, and substance use involved in cannabis oil vaporization. Adults with a medical cannabis registration card were recruited from a dispensary in Rhode Island and completed a 2-week study monitoring period using the Gram1 vaporizer, followed by a poststudy qualitative interview. The sample included nine adults who were predominantly male (89%), 100% White, and 100% non-Hispanic. The Gram1 collected topographical vaping data, and the cellphone application utilized ecological momentary assessment (EMA) to assess socioenvironmental factors and other substance use. Qualitative interview data were coded, and illustrative quotations were selected to support quantitative findings. A total of 224 vaping sessions were recorded reflecting 76.4% of the study monitoring period. There was an average of 1.79 vaping sessions per day across all days. Participants took 8.76 puffs on average (SD = 8.23) per vaping session, and the session lasted 2.59 min on average (SD = 4.19). Regular vaporization was exhibited across days of the week and hours of the day. EMA reports indicated that smoking cannabis flower was the most common additional mode of cannabis administration. This study utilized a naturalistic design with novel topographical data and EMA to characterize cannabis oil vaporization. These findings establish the feasibility of collecting objective, momentary data to better understand use behaviors which are critical to informing safe consumption. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabisMarijuana SmokingHallucinogensSubstance-Related DisordersAdultHumansMaleFemalePilot ProjectsVolatilizationCannabinoid Receptor Agonists

Substanzen

HallucinogensCannabinoid Receptor Agonists

Autor:innen und Institutionen

  • Department of Psychology, Rutgers.
  • Center for Alcohol and Addiction Studies, Brown University School of Public Health.

ORCID-Profile: Jacqueline E Smith

Förderung

  • NIGMS NIH HHS
  • Brown University
  • National Institute of General Medical Sciences

Zitieren

APA

Smith, J. E., Aston, E. R., & Farris, S. G. (2024). A preliminary characterization of cannabis oil use and vaporization among individuals who use for medical purposes: A pilot study. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000672

Vancouver

Smith JE, Aston ER, Farris SG. A preliminary characterization of cannabis oil use and vaporization among individuals who use for medical purposes: A pilot study. Experimental and Clinical Psychopharmacology. 2024. doi:10.1037/pha0000672

BibTeX
@article{Smith2024,
  author = {Smith, Jacqueline E and Aston, Elizabeth R and Farris, Samantha G},
  title = {A preliminary characterization of cannabis oil use and vaporization among individuals who use for medical purposes: A pilot study},
  journal = {Experimental and Clinical Psychopharmacology},
  year = {2024},
  doi = {10.1037/pha0000672}
}
Kostenlos starten →